2023. Postbiotic driven immunomodulation: SCFAs as therapeutic agents in rheumatoid arthritis. Journal of Current Biomedical Reports. 4, 4 (Dec. 2023), 141–142. DOI:https://doi.org/10.61882/jcbior.4.4.292.